SCHEMBL513886

SCHEMBL513886

CCOC(C)=NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4154727 1.00
SCHEMBL513885 1.00
SCHEMBL8022541 0.77
SCHEMBL11621776 0.75
SCHEMBL8546157 0.75
SCHEMBL11996350 0.75
SCHEMBL23913817 0.73
SCHEMBL6036832 0.73
SCHEMBL10081779 0.73
SCHEMBL10063335 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934281-A1 1-PHENYL-BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS BAGA- A? RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 1999-08-11 EP claimed
WO-1998017651-A1 1-PHENYL-BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS BAGA-A RECEPTOR MODULATORS NEUROSEARCH A/S (DK) 1998-04-30 WO claimed
US-5075504-A Reacting nitrile with alcohol in presence of hydrogen halide, then treatment with aqueous carbonates and hydroxylamine salts basification, alkylation, acid hydrolysis CIBA-GEIGY CORPORATION (US) 1991-12-24 US claimed
EP-0440582-A1 Process for preparing O-substituted hydroxylamines CIBA-GEIGY AG (CH) 1991-08-07 EP claimed
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 WO disclosed
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
US-20260042731-A1 (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS CORTEVA AGRISCIENCE LLC (US) 2026-02-12 US disclosed
WO-2025121401-A1 PYRAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT 日産化学株式会社 2025-06-12 WO disclosed
US-20250129067-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2025-04-24 US disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 EP disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
EP-0158153-A2 Process for the preparation of N-hydroxy organo imidate compounds ALLIED CORPORATION (US) 1985-10-16 EP disclosed
US-4545807-A Oxime ester herbicides HOFFMANN-LA ROCHE INC. (US) 1985-10-08 US disclosed
EP-0041242-B1 CARBAMOYLOXYAMINO-1,4-BENZODIAZEPINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1984-07-11 EP disclosed
US-4435207-A Quinyloxy-phenyloxy-oxime ester compounds having herbicidal activity HOFFMANN-LA ROCHE INC. (US) 1984-03-06 US disclosed
US-4404384-A HYPOTENSIVE, ANTISPASMODIC, CHOLERETIC AGENTS; ANTICONUULSANTS; ANTIPYRETICS; ANTHELMINTICS; FUNGICIDWS HOECHST AKTIENGESELLSCHAFT (DE) 1983-09-13 US disclosed
US-4395409-A ANXIOLYTIC AGENT HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-26 US disclosed
US-4150043-A 0-(2,3-Epoxypropyl)-hydroximic acid esters HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-17 US disclosed
US-3709920-A METHYLENE-O,O{40 -BIS(ETHYLACETHYDROXIMATE) US AIR FORCE 1973-01-09 US disclosed